Steven Pfanstiel, a seasoned financial executive with extensive medical technology and pharmaceutical experience, replaces Steve Furlong as Chief Financial Officer following previously announced ...

Esketamine monotherapy is linked to greater 28-day symptom reduction in treatment-resistant depression vs placebo, new research shows.

More than thirty years since its 1993 founding, Catherine Owen Adams and Elizabeth Thompson—the R&D combo that has led Acadia ...

Market reaction to recent readouts from Compass Pathways and Beckley Psytech/atai in treatment-resistant depression speaks to ...

We need a resurgence of enthusiasm and encouragement for those able to develop alternative and more effective treatments, so ...

When Matt Thierfelder began his career as a Vancouver firefighter in 1994, the weight of unspoken rules hung over him: Don’t show weakness and don’t be vulnerable.

Florida is stepping up its efforts to help abate veteran suicide by agreeing to spend $300,000 this year to expand statewide ...

RISE Integrated Mental Health in York, Maine, offers ketamine therapy for trauma and depression, attracting patients ...

BSA Behavioral Health announced it is expanding its mental health services to include Spravato (esketamine) nasal spray, for ...

This new commentary explores where psychedelic mental health treatments might be heading and what needs to happen next.

We are so excited to partner with our colleagues at GBCC, Oasis, and MCA.” — Carrie Singer, PsyD, founder of Orchard Mental Health Group. With a combined legacy of nearly 50 years of community service ...

The Department of Veterans Affairs partners with Big Pharma to fuel “treatment” that triggers the very suicides it claims to ...